| scholarly article | Q13442814 |
| P50 | author | Nicholas Russell | Q86449566 |
| P2093 | author name string | Mark E Cooper | |
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Mitotoxicity in distal symmetrical sensory peripheral neuropathies | Q28834071 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes | Q34042084 | ||
| Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study | Q34433105 | ||
| Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype | Q35764301 | ||
| GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration | Q36526013 | ||
| MicroRNAs: potential mediators and biomarkers of diabetic complications. | Q37146727 | ||
| AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function | Q37259208 | ||
| Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? | Q37686261 | ||
| COMPLICATIONS OF DIABETES MELLITUS WITH SPECIAL REFERENCE TO CAUSE AND PREVENTION. | Q37733330 | ||
| Encephalopathies: the emerging diabetic complications | Q37783543 | ||
| Epigenetics: mechanisms and implications for diabetic complications | Q37819518 | ||
| Mechanisms of diabetic complications. | Q38072902 | ||
| Glycemic variability: both sides of the story | Q41946046 | ||
| Insulin signaling to the glomerular podocyte is critical for normal kidney function | Q42110064 | ||
| Basal insulin and cardiovascular and other outcomes in dysglycemia | Q42507791 | ||
| Combined angiotensin inhibition for the treatment of diabetic nephropathy | Q46129784 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis | Q56991358 | ||
| Changes in diabetes-related complications in the United States, 1990-2010 | Q64125961 | ||
| P433 | issue | 8 | |
| P921 | main subject | hyperglycemia | Q271993 |
| P304 | page(s) | 1708-1714 | |
| P577 | publication date | 2015-04-24 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications | |
| P478 | volume | 58 |
| Q26747251 | "Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 Diabetes |
| Q36064796 | Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone |
| Q26739955 | Bioactive Compounds and Their Neuroprotective Effects in Diabetic Complications |
| Q48037644 | Diabetologia at 50: celebrating half a century of progress in diabetes research and care |
| Q28079163 | Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity? |
| Q37510406 | High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy. |
| Q57091823 | High-Intensity Interval Training Is Equivalent to Moderate-Intensity Continuous Training for Short- and Medium-Term Outcomes of Glucose Control, Cardiometabolic Risk, and Microvascular Complication Markers in Men With Type 2 Diabetes |
| Q92170714 | Low frataxin mRNA expression is associated with inflammation and oxidative stress in patients with type 2 diabetes |
| Q30844796 | MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy |
| Q34045439 | Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes. |
| Q50087904 | Pro-apoptotic effects of microRNA-365 on retinal neurons by targeting IGF-1 in diabetic rats: an in vivo and in vitro study |
| Q38880678 | Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes. |
| Q64101221 | Severe Hypoglycemia as a Predictor of End-Stage Renal Disease in Type 2 Diabetes: A National Cohort Study |
| Q33749208 | The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications |
| Q28077454 | Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease |
Search more.